Transamerica Financial Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Transamerica Financial Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.85K	Buy	16 +6	+60%	+$1.31K	﹤0.01%	1184
2026 Q1	$1.89K	Hold	10	–	–	﹤0.01%	1222
2025 Q4	$1.7K	Sell	10 -2	-17%	-$307	﹤0.01%	1160
2025 Q3	$1.58K	Buy	+12	New	+$1.44K	﹤0.01%	1087
2021 Q3	–	Sell	-5	Closed	-$1K	–	163
2021 Q2	$1K	Buy	+5	New	+$866	0.02%	142
2016 Q2	–	Sell	-73	Closed	-$10K	–	551
2016 Q1	$10K	Sell	73 -253	-78%	-$31.5K	﹤0.01%	551
2015 Q4	$46K	Hold	326	–	–	﹤0.01%	416
2015 Q3	$44K	Sell	326 -1,461	-82%	-$252K	﹤0.01%	402
2015 Q2	$315K	Sell	1,787 -34	-2%	-$6.11K	0.02%	282
2015 Q1	$315K	Sell	1,821 -864	-32%	-$148K	0.02%	284
2014 Q4	$440K	Buy	2,685 +910	+51%	+$151K	0.03%	200
2014 Q3	$285K	Sell	1,775 -239	-12%	-$36.7K	0.03%	228
2014 Q2	$297K	Buy	+2,014	New	+$279K	0.03%	237

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Transamerica Financial Advisors's JAZZ Position: Q2 2026 in Review

Transamerica Financial Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 60% in Q2 2026, buying an estimated $1.31K and bringing the position to 16 shares worth $3.85K. The position accounts for ﹤0.01% of the portfolio, ranked #1184.

Transamerica Financial Advisors first reported a position in JAZZ in Q2 2014 and has held it in 13 quarters since. The position peaked at $440K in Q4 2014. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Transamerica Financial Advisors held 16 shares of Jazz Pharmaceuticals worth $3.85K as of Q2 2026.
Transamerica Financial Advisors bought 6 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.31K.
Jazz Pharmaceuticals made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1184 holding.
Transamerica Financial Advisors first reported a position in Jazz Pharmaceuticals in Q2 2014 and has held it in 13 quarters since.
Transamerica Financial Advisors's Jazz Pharmaceuticals position peaked at $440K in Q4 2014.
647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.